A new preclinical model for thymic cancer developed by Weill Cornell Medicine investigators has revealed insights into how a common mutation found in thymic epithelial tumors sparks their formation.

Association of immune-related adverse events with survival and treatment outcomes in thymic tumors treated with immune checkpoint inhibitors. Comparing impact of treatment before or after surgery in ...

Thymoma and thymic carcinoma are two types of thymus cancer. The thymus is a small organ in the upper chest. It’s in front of and above the heart. It makes white blood cells that help your body ...

Thymic lymphoma is a type of blood cancer. It happens when white blood cells called lymphocytes become cancerous. These types of blood cells come from the thymus gland, which sits behind your ...

Thymic epithelial tumors are a rare group of malignancies originating in the thymus gland, that includes thymoma and thymic carcinoma. Among these, thymic carcinoma is the more aggressive subtype ...

In addition to City of Hope scientists, the paper "Recirculating regulatory T cells mediate thymic regeneration through amphiregulin following thymic damage" included authors from Memorial Sloan ...

The epithelial cells, known as TECs (thymic epithelial cells), are further classified into cTECs (cortical TECs) and mTECs (medulla TECs). Thymic organogenesis is governed by the highly potent ...

Interleukin-4 receptor α (IL-4Rα), a shared receptor subunit for both IL-4 and IL-13, along with thymic stromal lymphopoietin ...

Thus, in thymic aplasia humoral immunity is normal, but cellular immunity is deficient, findings precisely the reverse of what is found in congenital agammaglobulinemia. The dichotomy found ...

Thymmune Therapeutics Inc. has secured US$7 million in seed financing to support its work in developing scalable thymic cell therapies to restore immune function in aging and disease. BioWorld Science ...